AstraZeneca Plots $200 Million Expansion In Frederick

Drug giant AstraZeneca will expand its biologics manufacturing center in Frederick and add hundreds of jobs to its operations there.

The drug giant will spend more than $200 million to increase production capacity. MedImmune, AstraZeneca's biologics research and development arm, has more than 120 drugs in its research pipeline, including more than 30 in clinical development. AstraZeneca says the expansion will support its research.

London-based AstraZeneca acquired Gaithersburg-based MedImmune in 2007 for $15.6 billion.

More